Weight Loss/Weight Management (Obesity) Pipeline Insight, 2024: Drugs Under Development, Unmet Needs, Key Players, Collaborations, Licensing Agreement And Financing Details

(MENAFN- GlobeNewsWire - Nasdaq) Dublin, May 08, 2024 (GLOBE NEWSWIRE) -- The "Weight Loss/Weight Management (Obesity) - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets's offering.
This report outlays comprehensive insights of present clinical development scenario and growth prospects across the Weight Loss/Weight Management (Obesity) market. A detailed picture of the pipeline landscape is provided, which includes the disease overview and treatment guidelines.

The assessment part of the report embraces an in-depth commercial assessment and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. In the report, a detailed description of the drug is proffered including mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, licensing, mergers and acquisition, funding, designations, and other product-related details.
The report provides insights into:

• All of the companies that are developing therapies for the treatment of Weight Loss/Weight Management (Obesity) with aggregate therapies developed by each company for the same.
• Different therapeutic candidates segmented into early-stage, mid-stage and late stage of development for the Weight Loss/Weight Management (Obesity) treatment.
• Weight Loss/Weight Management (Obesity) key players involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of Weight Loss/Weight Management (Obesity) market.

Key Topics Covered
1. Report Introduction
2. Weight Loss/Weight Management (Obesity)
3. Weight Loss/Weight Management (Obesity) Current Treatment Patterns
4. Weight Loss/Weight Management (Obesity) - Analytical Perspective
5. Therapeutic Assessment
6. Weight Loss/Weight Management (Obesity) Late Stage Products (Phase-III)
7. Weight Loss/Weight Management (Obesity) Mid Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Weight Loss/Weight Management (Obesity) Discontinued Products
13. Weight Loss/Weight Management (Obesity) Product Profiles
14. Weight Loss/Weight Management (Obesity) Key Companies
15. Weight Loss/Weight Management (Obesity) Key Products
16. Dormant and Discontinued Products
17. Weight Loss/Weight Management (Obesity) Unmet Needs
18. Weight Loss/Weight Management (Obesity) Future Perspectives
19. Weight Loss/Weight Management (Obesity) Analyst Review
20. Appendix
21. Report Methodology
For more information about this clinical trials report visit

About ResearchAndMarkets
ResearchAndMarkets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

MENAFN08052024004107003653ID1108187494